Sign in
WithdrawnPhase 3

Adenosine's Effect on STunning Resolution in Acute Myocardial Infarction

Key facts

Who runs it
Vastra Gotaland Region
Trial code
Status
Withdrawn
Phase
Phase 3
Started
1 Jan 2023
Ended
Dec 2025
Type of study
Interventional, 2 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • Adenosine
Record updated
17 May 2024
Why it stopped
Never started

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 11 criteriaShow less

Who can take part

  • Age >18 years
  • Anterior STEMI
  • Symptom duration ≤6 hours
  • Written informed consent obtained - Angiographic Inclusion criteria:; Culprit lesion in LAD, major branch of LAD, proximal or mid LCx or proximal or mid RCA; TIMI flow ≤2 in the culprit vessel; -Echocardiographic inclusion criteria:; Detectable hypo- or akinesia corresponding to ≥5% of the left ventricle corresponding to culprit lesion, per bedside visual assessment

Who cannot take part

  • Previous randomization in the study
  • Any of the following contraindications for treatment with adenosine:; Known pre-existing atrioventricular block grade ≥2 or sick sinus syndrome in patients without pacemaker; Known pre-existing elevation of intracranial pressure; Treatment with dipyridamole within 24 hours of randomization; Systolic blood pressure <80 mm Hg at screening
  • Any concomitant condition resulting in a life expectancy of less than one month
  • Previous myocardial infarction or other cardiac condition resulting in impaired regional or global systolic function without documented recovery of cardiac function
  • Heart transplant or left ventricular assist device recipient
  • Not suitable in the opinion of the investigator due to severe or terminal comorbidity with poor prognosis or characteristics that may interfere with adherence to the trial protocol
  • Pregnancy or woman of childbearing potential who is not sterilized or using a medically accepted form of contraception -

About the trial

What the trial wants to find out

The aim of this study is to evaluate the effect of adenosine on the recovery of myocardial akinesia in ST-elevation myocardial infarction (STEMI). The study is a single-center randomized clinical trial intending to include 90 patients.

Read full original descriptionShow less

The objective of the study is to investigate whether treatment with adenosine hastens recovery of myocardial akinesia and improves cardiac function at 48 hours in patients with STEMI.

The 2 groups in the trial

  • AdenosineTreatment being tested

    Adenosine infusion 70 µg/kg/min initiated prior to revascularization and maintained for 6 hours

  • ControllNo study treatment, for comparison

    Standard of care

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Adenosine's Effect on STunning Resolution in Acute Myocardial Infarction An Open-label, Single Center Trial
Record updated
17 May 2024